Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,255.40
+11.000.88%
Post-market: 1,254.06-1.3400-0.11%19:59 EDT
Volume:2.50M
Turnover:3.14B
Market Cap:1.19T
PE:42.14
High:1,271.22
Open:1,232.00
Low:1,230.00
Close:1,244.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.91
T/O Rate:0.27%
Dividend:6.46
Dividend Rate:0.51%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:35.03
PE(LYR):54.70

Loading ...

Believe it is Medically Appropriate to Make Authentic Retatrutide Available Before FDA Approval for Patients Meeting Some Criteria -Lilly Spokesperson

THOMSON REUTERS
·
Aug 04

Eli Lilly tells Stat it will let more patients apply for retatrutide access

TIPRANKS
·
Aug 04

Movement Alert|Eli Lilly Falls 3.21% in Regular Trading, Pipeline Breakthrough Overshadowed by GLP-1 Growth Concerns and Sector Weakness

Market Focus
·
Aug 03

Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Benzinga_recent_news
·
Aug 03

Lilly's Olomorasib Receives U.S. FDA's Breakthrough Therapy Designation for the Treatment of Previously Treated Kras G12c-Mutant Advanced Pancreatic Cancer

THOMSON REUTERS
·
Aug 03

Eli Lilly Stock Leads 3 Pharma Picks As Merger Talk Shakes Big Drugmakers

Simply Wall St.
·
Aug 03

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Jobs Report; Palantir, AMD, SpaceX, and Eli Lilly Earnings Reports: What to Watch This Week

Dow Jones
·
Aug 03

Earning Preview: Eli Lilly Q2 revenue is expected to increase by 40.78%, and institutional views are bullish

Earnings Agent
·
Aug 02

Ratio Therapeutics Announced Closing of a $70 Million Series C Financing

Reuters
·
Jul 31

Ratio Therapeutics: Financing Included Participation from Bristol Myers Squibb, Eli Lilly and Company, Wasatch Group & More

THOMSON REUTERS
·
Jul 31

BREAKINGVIEWS-Eli Lilly is Pharma’s Latest Victim of Success

Reuters
·
Jul 31

Here Comes the Next Wave of GLP-1s. They'll Treat a Lot More than Obesity.

Dow Jones
·
Jul 31

Eli Lilly & Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

Eli Lilly and Co Stock (LLY) Moved Down by 4.09% on Jul 30: Key Drivers Unveiled

TradingKey
·
Jul 30

Eli Lilly Expands Collaboration With Resilience to Boost KwikPen Production

MT Newswires Live
·
Jul 30

Movement Alert|Eli Lilly Declines 3.09% in Regular Trading, Pharma Sector Selloff Compounded by Novo Nordisk Litigation Pressure

Market Focus
·
Jul 30

Eli Lilly (LLY) Is Investing Another $750 Million in Its U.S. Manufacturing Facilities

TIPRANKS
·
Jul 30

Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock

Benzinga_recent_news
·
Jul 30

Resilience and Lilly Invest $750 Mln to Increase U.S.-Manufactured Medicine Supply

THOMSON REUTERS
·
Jul 30